Amendment: SEC Form SC 13G/A filed by Luna Innovations Incorporated
$LUNA
Biotechnology: Commercial Physical & Biological Resarch
Health Care
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
7/28/2023 | $12.50 | Buy | Stifel |
5/22/2023 | $10.00 | Buy | Needham |
3/15/2023 | $8.00 | Outperform → Market Perform | Northland Capital |
5/23/2022 | $8.00 | Market Perform → Outperform | Northland Capital |
Stifel initiated coverage of Luna Innovations with a rating of Buy and set a new price target of $12.50
Needham initiated coverage of Luna Innovations with a rating of Buy and set a new price target of $10.00
Northland Capital downgraded Luna Innovations from Outperform to Market Perform and set a new price target of $8.00